These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1261738)

  • 1. [Antigen therapy in chronic brucellosis].
    Roux J
    Dev Biol Stand; 1976; 31():227-9. PubMed ID: 1261738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for Brucella melitensis-associated antigens.
    Geraci D; Locorotondo G; Parlato A; Cocchiara R; Caracappa S; Scarlata F; Cascio A
    Microbiologica; 1988 Jul; 11(3):213-8. PubMed ID: 3173124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of various methods of therapy of chronic brucellosis].
    Mukovozova LA
    Ter Arkh; 1987; 59(11):93-6. PubMed ID: 3502037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis.
    Jiménez de Bagüés MP; Marín CM; Barberán M; Blasco JM
    Vaccine; 1993; 11(1):61-6. PubMed ID: 8427038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistence of serologic and allergic reactions in ewes after vaccination with the H.38 or Rev.1 vaccines in a brucellosis (Brucella melitensis) enzootic area].
    Pardon P; Sanchis R; Molenat G; Bouchard N; Schmitt D; Marly J; Durand M
    Ann Rech Vet; 1989; 20(1):65-72. PubMed ID: 2930135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against Brucella infections. Priming of Cynomolgus philipinensis with purified antigen of Brucella melitensis prior to injection of Rev. I vaccine.
    Chen TH; Elberg SS
    J Comp Pathol; 1973 Jul; 83(3):357-67. PubMed ID: 4199459
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brucellosis vaccine and thyroidin in the treatment of brucellosis in patients with decreased allergic reactivity].
    Lopatina ZhM
    Klin Med (Mosk); 1972 Sep; 50(9):94-6. PubMed ID: 4652982
    [No Abstract]   [Full Text] [Related]  

  • 9. [Course of chronic brucellosis in mice is not improved by administration of a vaccinal antigen].
    Plommet M; Plommet AM; Bosseray N
    Ann Rech Vet; 1982; 13(2):127-32. PubMed ID: 6820248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods of reduction of reactogenic effect of therapeutic vaccine in hyper-reactive patients with brucellosis].
    Otaraev IB; Otaraeva BI; Butaeva AR
    Klin Med (Mosk); 1975 Oct; 53(10):121-5. PubMed ID: 1230564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of certain indicators of immunity in patients with chronic brucellosis during vaccine therapy].
    Kugot AS
    Klin Med (Mosk); 1975 Feb; 53(2):57-60. PubMed ID: 1186063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccine-pyrogenal therapy of patients with brucellosis with low allergic reactivity].
    Lopatina AM
    Ter Arkh; 1972 May; 44(5):100-3. PubMed ID: 5069063
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effectiveness of levamisole and vaccine in the complex treatment of patients with brucellosis].
    Mukovozova LA
    Ter Arkh; 1986; 58(10):43-5. PubMed ID: 3541274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental evaluation of the brucellosis therapeutic vaccine efficacy].
    Shabalin BA; Okhapkina VIu; Gavrilova LB; Saiapina LV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (2):38-43. PubMed ID: 17523477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological titres following vaccination of sheep and goats with Brucella melitensis rev I vaccine.
    Worthington RW; Mülders MS; McFarlane IS; Becker D
    Onderstepoort J Vet Res; 1973 Mar; 40(1):1-5. PubMed ID: 4197921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous-intradermal vaccine therapy in brucellosis].
    Lopatina ZhM; Trug AD
    Sov Med; 1973 Aug; 36(8):142. PubMed ID: 4777109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of increased sensitivity to microbial allergens].
    Beklemishev ND
    Sov Med; 1973 Nov; 36(11):19-25. PubMed ID: 4787426
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tactics of treating brucellosis with early extinction of reactions to the intravenous administration of vaccine].
    Lopatina ZhM; Trug AD
    Ter Arkh; 1972 Feb; 44(2):91-4. PubMed ID: 5039710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.